Isn't that a crazy price!!! That's where I got all my March $2's. Not many times you can have an opportunity for a legitimate 20 to 60+ bagger!!! Not unless you're really playing the pennies. Your $2.50 mark by December would be nice, but I'm hoping closer to double that by March. Guess I'm even more optimistic than you. Has a chance to make it to those marks, in a heartbeat IMO. Looking to see some news out early next week. Would love to see a halt on this stock next week. An option traders dream and nightmare rolled into one. Would be the former with Pluristem, as I don't see what news could be bad. Show us this run is happening for a reason.
Now saying that, not sure what will happen with the moods everywhere if this move was just a head fake. If we start drifting back to the $1.50 mark, all those drinks will be to drown sorrow, not celebrate. Little premature to break out the champagne.
Only thing I worry about is what the twins seem best at...missing deadlines. Not a big deal with shares, but deadly for options. Only 11 more weeks until the promised year is done. Here's a list of their milestones from January presentation. Only one has been achieved, and two are 15 weeks late. Not even going to talk about the Japanese partnership and how unbelievably late they are since that was first promised. Not going to get number 3 until 2 is completed. With DOD also involved now, seems much more likely they will hammer it out. Better be this year as promised!!!
1. Data readout dose selection studies ARS-H1/2017
2. Contract with U.S. government for ARS–H2/2017
3. Initiation of pivotal study ARS NHP-H2/2017
4. Data read out phase I open label HCT-H2/2017
5. Preclinical data Fukushima-H1/2017
6. Preclinical data NYBC-H1/2017
